Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |